Myth 1: Peptides are natural, so they are safe.
Your body makes peptides, but that does not make every synthetic, compounded, or research peptide safe for every person. Dose, route, purity, sterility, and medical history all matter.
Myth 2: A COA makes a vial legitimate.
A COA can be useful batch documentation, but it does not replace a prescription, sterile handling, pharmacy controls, or clinical eligibility review.
Myth 3: More peptides means better results.
Stacking can make a protocol harder to interpret and riskier to adjust. More moving parts can mean less clarity.
A certificate of analysis tells you what is in the vial. It does not tell you whether you should be injecting it.
Myth 4: Research-only products are a clever workaround.
If a product is sold as research-only but discussed for personal injection, that is a safety red flag. You may not have the same protections, documentation, or accountability as prescription care.
Myth 5: Compounded means FDA-approved.
FDA states that compounded drugs are not FDA-approved. They can be clinically useful in appropriate circumstances, but they are not reviewed by FDA for safety, effectiveness, or quality before marketing.
Better rule
When a claim sounds effortless, ask: who reviewed the patient, who made the medication, what evidence supports the use, what can go wrong, and what is the follow-up plan?
Sources